ADAMTS13 and thrombotic thrombocytopenic purpura: Decision for early plasma exchange is often taken because of its benefits for several TMA subforms but foremost because definite exclusion of TTP is not immediately possible in clinical practice due to the delay caused by assessment of ADAMTS-13 activity and antibodies.